Abstract-We investigated the relationship between the day-night blood pressure (BP) dip and the early morning BP surge in an cohort of 3012 initially untreated subjects with essential hypertension. The day-night reduction in systolic BP showed a direct association with the sleep trough (rϭ0.564; PϽ0.0001) and the preawakening (rϭ0.554; PϽ0.0001) systolic BP surge. Over a mean follow-up period of 8.44 years, 268 subjects developed a major cardiovascular event (composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and heart failure requiring hospitalization) and 220 subjects died. In a Cox model, after adjustment for predictive covariates, including age, sex, diabetes mellitus, cigarette smoking, total cholesterol, left ventricular hypertrophy on ECG, estimated glomerular filtration rate, and average 24-hour systolic BP, a blunted sleep trough (Յ19.5 mm Hg; quartile 1) and preawakening (Յ9.5 mm Hg; quartile 1) BP surge was associated with an excess risk of events (hazard ratio, 1.66 [95% CI, 1.14 -2.42]; Pϭ0.009; hazard ratio, 1.71 [95% CI, 1.12-2.71]; Pϭ0.013). After adjustment for the same covariates, neither the dipping pattern nor the measures of early morning BP surge were independent predictors of mortality. In conclusion, in initially untreated subjects with hypertension, a blunted day-night BP dip was associated with a blunted morning BP surge and vice versa. In these subjects, a blunted morning BP surge was an independent predictor of cardiovascular events, whereas an excessive BP surge did not portend an increased risk of events. (Hypertension. 2012;60:00-00.)
O ccurrence of major cardiovascular complications, including myocardial infarction (MI), 1 stroke, 2 and sudden cardiac death, 3 peaks in the early morning hours, typically in the first 4 to 6 hours after awakening. Therefore, the hypothesis has been raised that the extent of blood pressure (BP) surge in the early morning may be associated with the risk of cardiovascular complications. This hypothesis is potentially relevant because it might imply the possibility that reducing the early morning rise in BP may lower the risk of major events that occur in the early morning. By using 24-hour ambulatory BP (ABP) monitoring in cohorts of hypertensive patients [4] [5] [6] or randomized samples from the general population, 7, 8 several investigators examined the association between the morning BP surge and the subsequent outcome, but results were not univocal. On the other hand, many studies showed that the risk of cardiovascular disease directly increases with nighttime BP and a blunted BP dip from day to night. 6, [9] [10] [11] [12] The adverse prognostic impact of a blunted or reversed diurnal BP rhythm seems difficult to reconcile with the hypothesis that an excessive rise in BP from the nighttime period to the early morning is also predictive of a worse outcome.
None of the studies that addressed the morning BP surge were specifically conducted in large cohorts of subjects with hypertension who were untreated at the time of 24-hour ABP monitoring, thus avoiding the potential interference of antihypertensive treatment and timing of administration. In addition, long duration of follow-up and availability of several clinical and experimental confounders measured at baseline were not always present in earlier reports. Accordingly, we examined a large observational study of initially untreated hypertensive patients in whom baseline assessment of ABP and several variables were available.
Methods
The Progetto Ipertensione Umbria Monitoraggio Ambulatoriale Study, established in June 1986, is a prospective observational registry of morbidity and mortality in initially untreated subjects with essential hypertension. The registry was approved by the local ethics committee of the Italian National Health Service, and all of the subjects provided their informed consent to participate. Details of the study have been published. 12, 13 Entry criteria include an office BP Ն140 mm Hg systolic and/or Ն90 mm Hg diastolic on Ն3 visits and absence of secondary causes of hypertension, previous cardiovascular disease, or life-threatening conditions. Shift workers were excluded. BP was measured by a physician with a mercury sphygmomanometer with subjects sitting and relaxed for Ն10 minutes. Cuff size was adjusted to arm circumference. Three measurements were averaged for analysis. Systolic and diastolic BPs were identified by Korotkoff phases I and V.
We recorded 12-lead ECG at 25-mm/s and 1-mV/cm calibration. We excluded subjects with complete right-or left-bundle branch block, previous MI, Wolff-Parkinson-White syndrome, and atrial fibrillation at entry. None of the subjects were being treated with digitalis. We diagnosed left ventricular (LV) hypertrophy by ECG by using a score developed in our laboratory, which requires positivity of Ն1 of the following 2 criteria, SV 3 ϩRaVL Ͼ2.4 mV (men) or Ͼ2.0 mV (women) or typical LV strain. 14 We diagnosed diabetes mellitus by a fasting plasma glucose of Ն7.0 mmol/L (126 mg/dL) or current antidiabetic therapy.
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Ambulatory BP
ABP was recorded using an oscillometric device (SpaceLabs 5200, 16 90202, 17 and 90207, 18 SpaceLabs, Redmond, WA). Frequency of measurements was set to 1 every 15 minutes throughout the 24 hours. Daytime and nighttime ABPs were defined through the use of a diary reporting the time of awakening and retiring. Reproducibility of ABP readings in our subjects was examined in a previous study in which a random sample of untreated hypertensive subjects included in the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale registry repeated 24-hour BP monitoring within 3 to 5 days. 19 The betweensession coefficient of variability (SD of the mean of the paired differences between 2 sessions divided by the average of all paired means) was 5.9%/6.3% for daytime BP and 6.1%/6.3% for nighttime BP. 19 We determined the day-night reduction in BP from the nighttime and daytime ABP. To calculate the morning BP surge, we first determined the awake and asleep intervals from the subjects' diary. We determined the sleep-trough morning BP surge as the difference between the average BP during the 2 hours after awakening and the lowest nighttime BP (ie, the average of the lowest BP and the 2 readings immediately preceding and after the lowest value). 4 We also determined the preawakening morning BP surge as the difference between the average BP during the 2 hours after awakening and the average BP during the 2 hours before awakening.
4,7
Follow-Up
Family doctors were in charge of follow-up of patients, in collaboration with our hospital staff. We tailored treatment on an individual basis by using lifestyle and pharmacological measures. Because results of baseline 24-hour ABP were made available to family doctors, it is difficult to anticipate to what extent these results influenced the management of the single subjects. The most frequently used antihypertensive drugs were thiazide diuretics, ␤-blockers, angiotensin-converting enzyme inhibitors, angiotensin II antagonists, calcium-channel blockers, and ␣ 1 -blockers, alone or combined. We planned periodical contacts with family doctors and telephone interviews and clinical visits with patients to ascertain the vital status and the occurrence of events.
Assessment of End Points
Hospital records and other source documents of patients who died or experienced a cardiovascular event were reviewed in conference and adjudicated by the authors of this study. We defined a composite pool of major cardiovascular events and all-cause mortality as terminating end points. The composite pool included nonfatal MI, nonfatal stroke, cardiovascular death, and congestive heart failure requiring hospitalization. Cardiovascular death was defined as a sudden cardiac death or a death caused by acute MI, acute stroke, heart failure, or other cardiovascular causes. Softer end points were not considered as terminating events. The international standard criteria used to diagnose outcome events in the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale Study have been described.
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Data Analysis
Data analysis was carried out using SPSS Statistics release 18 (SPSS Inc) and SAS release 9.2 (SAS Institute Inc). Parametric data are reported as meanϮSD. For subjects who experienced multiple events, analysis was restricted to the first event. Survival curves were estimated using Kaplan-Meier product-limit method and compared by the Mantel (log-rank) test with adjustment for multiple pairwise comparisons. The effect of prognostic factors on survival was evaluated by Cox semiparametric regression models. 20 The hazard ratio (HR) was tested after adjustment for the following variables, age, sex (women, men), diabetes mellitus (no, yes), serum cholesterol (in millimoles per liter), smoking habits (current smokers, nonsmokers), estimated glomerular filtration rate (GFR) based on the Modification of Diet in Renal Disease formula, 21 body mass index (in kilograms per meter squared), LV hypertrophy by ECG 14 (no, yes), antihypertensive therapy at the last follow-up contact before terminating event or censoring (lifestyle measures, drug treatment), type of BP recorder (5200, 90202, and 90207), and office systolic and diastolic BPs. ABP entered the model as average 24-hour BP (in millimeters of mercury), preawakening BP surge (in millimeters of mercury), and sleep-trough BP surge (in millimeters of mercury). We also categorized patients according to the extent of systolic BP reduction from day to night, 22 extreme dippers (Ն20%), dippers (10% to 19%), nondippers (0% to 9%), and reverse dippers (Ͻ0%). Two-sided P values Յ0.05 were considered statistically significant.
Results
The flow diagram of the study is reported in Figure 1 . Overall, 3792 subjects were consecutively included in the Progetto Ipertensione Umbria Monitoraggio Ambulatoriale registry from June 12, 1986 , to June 11, 2006 . Complete follow-up information was available for 3429 of these subjects. After exclusion of 417 subjects with BP Ͻ140 mm Hg systolic and Ͻ90 mm Hg at entry, 3012 subjects remained available for analysis. The main features of the population are shown in Table  1 . Mean age was 50.8 years, and women were 45.5%.
The division points for quartiles of sleep-trough BP surge were 19.50, 27.50, and 36.0 mm Hg. The division points for quartiles of the distribution of preawakening BP surge were 9.50, 17.50, and 27.50 mm Hg. The proportions of extreme dippers, dippers, nondippers, and reverse dippers were 13.6%, 54.8%, 27.8%, and 3.9%, respectively. The reduction in systolic BP from day to night showed a statistically significant direct association with the sleep trough (rϭ0. 
Outcome Events
During a mean follow-up period of 8.44 years, 268 subjects developed a major cardiovascular event (event rate of 1.05 [95% CI, 0.93-1.19]ϫ100 patient-years), and 220 subjects died (death rate of 0.86 [95% CI, 0.71-0.92]ϫ100 patientyears). Specifically, 50 patients developed a fatal cardiovascular event, 89 a nonfatal stroke, and 86 a nonfatal MI, and 43 were hospitalized for congestive heart failure.
Univariate Analyses
The rates of cardiovascular events were 0.57 (95% CI, 0.36 -0.88), 0.76 (95% CI, 0.63-0.92), 1.65 (95% CI, 1.37-1.98), and 3.06 (95% CI, 2.10 -4.46)ϫ100 patient-years in the categories of extreme dippers, dippers, nondippers, and reverse dippers, respectively. The Kaplan-Meier curves are reported in Figure 3 (log-rank 2 ϭ74.8; PϽ0.0001). After adjustment for multiple comparisons, failure rate was higher in nondippers (log-rank 2 ϭ33.1; PϽ0.0001) and reverse dippers (log-rank 2 ϭ39.6; PϽ0.0001) as compared with dippers, whereas extreme dippers and dippers did not differ significantly (log-rank 2 ϭ3.8; PϽ0.052). The rate of cardiovascular events increased with lower, not higher, values of sleep-trough BP surge (log-rank 2 ϭ15.9; Pϭ0.001; Figure 4 , left) and preawakening BP surge (logrank 2 ϭ33.9; PϽ0.0001; Figure 4 , right). After adjustment for multiple comparisons, event rate was higher in quartile 1 (log-rank 2 ϭ7.59; Pϭ0.018) of the sleep-trough systolic BP surge as compared with quartile 4, whereas differences between the other quartiles did not achieve significance. Similarly, after adjustment for multiplicity, event rate was higher in quartile 1 (log-rank 2 ϭ27.4; PϽ0.0001) of the preawakening systolic BP surge as compared with quartile 4.
Taking the quartile 4 of sleep-trough BP surge as reference, the unadjusted HR for cardiovascular events was 1.67 (95% CI, 1.19 -2.36), 1.40 (95% CI, 0.97-2.01), and 0.92 (95% CI, 0.61-1.37) in quartiles 1, 2, and 3, respectively. Similarly, taking the quartile 4 of preawakening BP surge as reference, the unadjusted HR for cardiovascular events was 2.34 (95% CI, 1.58 -3.45), 1.36 (95% CI, 0.89 -2.07), and 1.11 (95% CI, 0.73-1.71) in quartiles 1, 2, and 3, respectively ( Figure 5 ).
Multivariate Analysis: Dipping Pattern
After adjustment for predictive covariates including age, sex, diabetes mellitus, cigarette smoking, total cholesterol, LV hypertrophy on ECG, estimated GFR, and average 24-hour systolic BP, the risk of cardiovascular events was increased in values in patients in the bottom 90th percentile (Pϭ0.10 and 0.65, respectively). When the categorization of patients according to upper decile versus 90th percentile of sleepthrough or preawakening systolic BP surge entered the multivariate Cox model, it did not achieve significance either in the analysis of cardiovascular events or in that of total mortality.
Discussion
Our analysis is based on a cohort of 3012 subjects with hypertension who were untreated at the time of ABP monitoring. These subjects provided 25 433 patient-years of follow-up, 268 new cardiovascular events, and 220 all-cause deaths. The main findings were the significant direct association between BP dip from day to night and the BP surge after awakening and the increased risk of cardiovascular events in subjects with blunted morning BP surge. The latter finding was unexpected.
Previous Studies
Kario et al 4 followed for an average of 41 months a group of 519 older hypertensive subjects (mean age, 72 years) who were untreated at the time of ABP monitoring. There were 44 stroke events. After adjustment for age, sex, smoking, diabe- Time to First Cardiovascular Event, years 
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tes mellitus, hyperlipidemia, silent cerebrovascular ischemia, average 24-hour systolic BP, and dipping category (reverse dippers, nondippers, dippers, and extreme dippers), the sleeptrough systolic BP surge was associated with a 25% higher risk of stroke (Pϭ0.008), whereas preawakening BP surge did not achieve significance. 4 In a general population study from Japan, Metoki et al 7 followed for an average of 10.4 years a cohort of 1430 subjects aged 61 years, 27% of whom were under antihypertensive drugs at entry. There were 128 stroke events. After adjustment for age, sex, smoking, diabetes mellitus, cholesterol, previous cardiovascular disease, antihypertensive drugs at entry, and average 24-hour systolic BP, morning BP surge did not predict the risk of total stroke. Only the risk of hemorrhagic stroke was increased in the fifth quintile (Ն25 mm Hg) of the distribution of the morning BP surge (HR, 4.0 [95% CI, 1.08 -14.6]; Pϭ0.04). 7 In a study conducted in 507 white hypertensive subjects who were untreated at the time of ABP monitoring, Gosse et al 5 detected 31 first cardiovascular events after than a follow-up period of 92 months. After adjustment solely for age and 24-hour systolic BP, for each 1-mm Hg increase in preawakening systolic BP (the first systolic BP measure after standing and the last supine BP measure before standing), there was a 3.3% higher rate of events (Pϭ0.009).
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To our knowledge, the largest contribution to the prognostic value of the morning BP surge came from a recent analysis of the International Database of Ambulatory Blood Pressure in Relation to Cardiovascular Outcome. 8 Overall, 5645 general subjects randomly recruited from the general population in 8 countries, aged 61 years and 1 of 5 under antihypertensive treatment at entry, were followed for a median of 11.4 years. During this period there were 611 major cardiovascular 
The Present Study
At variance with previous investigations, a greater morning BP surge, either expressed as sleep-trough or preawakening surge, did not predict a greater cardiovascular risk in our study. Unexpectedly, the risk of cardiovascular events was increased, not decreased, in patients with a blunted preawakening BP surge. Such relationship remained significant in the multivariate analysis (Tables 3 and 4) . These findings could be explained by the direct association between the BP dip from day to night and the BP surge: the greater the day-night dip, the greater the morning BP surge and vice versa. Also, in the study by Metoki et al, 7 the amplitude of the morning BP surge showed a direct association (rϭ0.59) with the amplitude of the day-night BP dip. Some differences between the present study and previous studies deserve comment. At variance with previous investigations, we had the opportunity to test the prognostic value of the morning BP surge after adjustment not only for traditional risk factors (age, sex, diabetes mellitus, smoking, and cholesterol) and average 24-hour ABP but also for LV hypertrophy and estimated GFR, both of which are established measures of cardiovascular risk in hypertensive patients. 23 Thus, the significant prognostic value of the morning BP surge observed in previous studies might have reflected the influence of masked or unmeasured confounders. However, such a hypothesis does not explain why, in the present study, a blunted morning BP surge was associated with a higher, not lower, cardiovascular risk also when LV hypertrophy and estimated GFR were removed from the model. Furthermore, to improve comparability between our analysis and that of previous investigations, we also tested the impact of the upper decile of the morning BP surge as compared with the bottom 90th percentile, but results did not change. It is important to remark that our population is entirely composed of white hypertensive subjects who were not receiving antihypertensive drugs at the time of ABP monitoring. Masked or unmeasured factors potentially related to the ethnicity of the population, the demographic features at entry, and drug treatment could have contributed to explain the differences between our findings and those of previous studies. A final point to consider is that we restricted the definition of cardiovascular events to a composite pool of hard events (nonfatal MI, nonfatal stroke, cardiovascular death, and congestive heart failure requiring hospitalization), with exclusion of softer events.
Day-Night BP Dip
In the present study, we observed an increased rate of cardiovascular events in subjects with a blunted day-night BP dip and in those with reverse dip (ie, higher systolic BP at night than during day). 24 Such effect remained significant in the multivariate analysis after adjustment not only for traditional risk factors and the average 24-hour ABP but also for LV hypertrophy and estimated GFR, 2 variables associated with a flattened or reverse circadian BP rhythm. 25, 26 These data extend to a predominantly middle-age hypertensive population the evidence, obtained in a multinational elderly hypertensive cohort, that the adverse prognostic impact of a 
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blunted day-night BP dip is independent of the average 24-hour BP.
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Limitations of the Study
Because our study has been conducted in a white population, results should not be extended to different ethnic groups. Furthermore, our results are applicable to untreated subjects with clinical diagnosis of hypertension at the time of ABP monitoring. Finally, the potential impact of longitudinal variations in the morning BP surge and day-night BP dip could not be evaluated.
Conclusions
In initially untreated subjects with essential hypertension, the magnitude of BP dip from day to night was directly associated with the magnitude of the BP surge in the early morning. In these subjects, a blunted morning BP surge was an independent predictor of cardiovascular events. In contrast, an excessive BP surge did not portend an increased risk of events.
Perspectives
Contrary to our expectations, in our cohort of white and initially untreated subjects with hypertension, the magnitude of the early morning surge in BP did not contribute to improve cardiovascular risk stratification. Future studies should investigate whether factors including the ethnic group or the antihypertensive treatment may interfere with the prognostic value of the early morning surge in BP. In the meantime, we should continue to use 24-hour systolic BP and a blunted or reversed fall in systolic BP from day to night as independent variables for cardiovascular risk stratification.
Only a large prospective intervention trial would clarify whether a treatment strategy based on out-of-hospital BP is superior to a strategy based on traditional clinic BP for reducing the risk of cardiovascular complications. Such a trial, although immensely needed because of the explosive increase in the out-of-hospital BP measurements, is unlikely to be done because it is too expensive.
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Summary
In white and initially untreated hypertensive subjects, the magnitude of the early morning surge in BP does not improve cardiovascular risk stratification.
